Sinotherapeutics Inc. A (688247) — Free Cash Flow Generation Index
Sinotherapeutics Inc. A (688247) has a Free Cash Flow Generation Index of 0.56x as of December 2025. Free cash flow of CN¥53.77 Million represents 1% of operating cash flow (CN¥95.33 Million). See 688247 working capital ratio to evaluate short-term liquidity relative to the company's equity base.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Sinotherapeutics Inc. A Free Cash Flow Generation Index (2020–2025)
Historical FCF Generation Index trend for Sinotherapeutics Inc. A across 6 annual periods. Explore Sinotherapeutics Inc. A (688247) cash flow to debt to assess how comfortably operating cash covers total debt obligations.
Annual Free Cash Flow Generation for Sinotherapeutics Inc. A (2020–2025)
Year-by-year Free Cash Flow Generation Index for Sinotherapeutics Inc. A. For the full company profile including market capitalisation, see Sinotherapeutics Inc. A stock valuation.
| Year | FCG Index | Free Cash Flow (CNY) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.56x | CN¥53.77 Million | CN¥95.33 Million | CN¥41.56 Million | ▲ +108.1% |
| 2024 | 0.27x | CN¥35.30 Million | CN¥130.23 Million | CN¥94.93 Million | ▲ +113.5% |
| 2023 | -2.01x | CN¥-26.00 Million | CN¥12.96 Million | CN¥38.96 Million | ▼ -42.3% |
| 2022 | -1.41x | CN¥-103.15 Million | CN¥73.18 Million | CN¥176.34 Million | ▼ -258.3% |
| 2021 | 0.89x | CN¥129.77 Million | CN¥145.77 Million | CN¥16.01 Million | ▲ +8.9% |
| 2020 | 0.82x | CN¥171.70 Million | CN¥210.04 Million | CN¥38.34 Million | — |